Comparative effect of clopidogrel plus aspirin and aspirin monotherapy on hematological parameters using propensity score matching | Zendy

Masatoshi Hayasaka | Zendy; Yasuo Takahashi | Zendy; Nishida | Zendy; Yoshida | Zendy; Hidaka | Zendy; Hideki Asai | Zendy

Open Access

Comparative effect of clopidogrel plus aspirin and aspirin monotherapy on hematological parameters using propensity score matching

Author(s) -

Masatoshi Hayasaka,

Yasuo Takahashi,

Nishida,

Yoshida,

Hidaka,

Hideki Asai

Publication year - 2013

Publication title -

vascular health and risk management

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.892

H-Index - 68

eISSN - 1178-2048

pISSN - 1176-6344

DOI - 10.2147/vhrm.s39351

Subject(s) - medicine , aspirin , propensity score matching , clopidogrel , matching (statistics) , cardiology , pathology

Clopidogrel and aspirin are antiplatelet agents that are recommended to reduce the risk of recurrent stroke and other cardiovascular events. Dual antiplatelet therapy with clopidogrel and aspirin has been shown to increase the risk of hemorrhage, but the effects of the drugs on laboratory parameters have not been well studied in real-world clinical settings. Therefore, we evaluated and compared the effects of combination therapy with clopidogrel plus aspirin and aspirin monotherapy on laboratory parameters.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research